The Joint Clinical Assessment (JCA) is the European Union’s centralised evaluation of comparative clinical effects and safety for selected health technologies. It started to apply on 12 January 2025 under the EU Health Technology Assessment framework to address widespread duplication of national clinical assessments, improve methodological consistency across Member States, and provide a single clinical evidence base to support more efficient national decision-making.
